Rand Monaghan

Rand Monaghan is an accomplished finance professional currently serving as Vice President of Corporate Finance and Strategy at Dianthus Therapeutics, Inc. since March 2025. Prior experience includes various leadership roles at Lexeo Therapeutics from January 2022 to March 2025, including Vice President of Finance and Senior Director of Finance and Corporate Strategy. Previous positions at Bristol Myers Squibb and Celgene involved strategic planning and corporate finance in the biopharmaceutical sector. Rand's career began in investment banking at Citi, where roles ranged from Healthcare Investment Banking Senior Analyst to Associate. Rand holds an MBA from Columbia Business School and a Bachelor's Degree in Accounting and Finance from Lehigh University.